OlympiAD: Health-related quality of life (HRQoL) in patients with HER2-negative metastatic breast cancer (mBC) and a germline BRCA mutation (gBRCAm) receiving olaparib monotherapy vs standard single-agent chemotherapy treatment of physician's choice (TPC)

被引：0

作者：

Robson, M. ^{[1
]}

Ruddy, K. J. ^{[2
]}

Im, S-A. ^{[3
]}

Senkus-Konefka, E. ^{[4
]}

Xu, B. ^{[5
,6
]}

Domchek, S. M. ^{[7
]}

Masuda, N. ^{[8
]}

Delaloge, S. ^{[9
]}

Li, W. ^{[10
]}

Tung, N. ^{[11
]}

Armstrong, A. ^{[12
,13
]}

Wu, W. ^{[14
]}

Goessl, C. ^{[14
]}

Degboe, A. ^{[14
]}

Conte, P. F. ^{[15
,16
]}

机构：

[1] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA

[2] Mayo Clin, Rochester, NY USA

[3] Seoul Natl Univ, Coll Med, Seoul Natl Univ Hosp, Res Inst, Seoul, South Korea

[4] Med Univ Gdansk, Gdansk, Poland

[5] Chinese Acad Med Sci, Beijing, Peoples R China

[6] Natl Canc Ctr, Canc Hosp, Peking Union Med Coll, Beijing, Peoples R China

[7] Univ Penn, Basser Ctr, Philadelphia, PA 19104 USA

[8] Natl Hosp Org, Osaka Natl Hosp, Osaka, Japan

[9] Inst Gustave Roussy, Villejuif, France

[10] First Hosp Jilin Univ, Changchun, Jilin, Peoples R China

[11] Beth Israel Deaconess Med Ctr, Dana Farber Harvard Canc Ctr, Boston, MA 02215 USA

[12] Christie Hosp NHS Fdn Trust, Manchester, Lancs, England

[13] Fac Biol Med & Hlth, Manchester, Lancs, England

[14] AstraZeneca, Gaithersburg, MD USA

[15] Univ Padua, Padua, Italy

[16] IRCCS, Ist Oncol Veneto, Padua, Italy

来源：

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

290P

引用

页数：1